# Health and Human Services Department — the long-form archive Everything Health and Human Services Department has published while this archive has been running: 175 documents across 20 days, oldest first. Coverage begins on 2026-08-10, which is when this archive started holding Federal Register issues — not when the agency started publishing. Anything earlier is absent from this page and its absence is not evidence. [HTML](https://downstream.sh/daily/agency/health-and-human-services-department/archive.html) · [the last five days](https://downstream.sh/daily/agency/health-and-human-services-department/index.md) ## 10 August 2026 — 10 documents - **Notice** [Office of the Director, Notice of Charter Renewal](https://www.federalregister.gov/documents/2026/08/10/2026-16257/office-of-the-director-notice-of-charter-renewal) · `2026-16257` - **Notice** [Determination That OZOBAX (Baclofen) Oral Solution, 5 Milligrams/5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/08/10/2026-16248/determination-that-ozobax-baclofen-oral-solution-5-milligrams5-milliliters-was-not-withdrawn-from) · `2026-16248` - **Notice** [Determination of Regulatory Review Period for Purposes of Patent Extension; BRINSUPRI](https://www.federalregister.gov/documents/2026/08/10/2026-16247/determination-of-regulatory-review-period-for-purposes-of-patent-extension-brinsupri) · `2026-16247` - **Notice** [Determination of Regulatory Review Period for Purposes of Patent Extension; DAYVIGO](https://www.federalregister.gov/documents/2026/08/10/2026-16246/determination-of-regulatory-review-period-for-purposes-of-patent-extension-dayvigo) · `2026-16246` - **Notice** [Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-GRAIL, Inc. Galleri](https://www.federalregister.gov/documents/2026/08/10/2026-16245/molecular-and-clinical-genetics-panel-of-the-medical-devices-advisory-committee-notice-of-meeting) · `2026-16245` - **Notice** [Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Transforming Pediatrics for Early Childhood Program Performance Measures](https://www.federalregister.gov/documents/2026/08/10/2026-16227/agency-information-collection-activities-submission-to-omb-for-review-and-approval-public-comment) · `2026-16227` - **Proposed Rule** [Radiology Devices; Reclassification of Digital Breast Tomosynthesis System](https://www.federalregister.gov/documents/2026/08/10/2026-16209/radiology-devices-reclassification-of-digital-breast-tomosynthesis-system) · `2026-16209` - **Notice** [National Institute on Deafness and Other Communication Disorders; Notice of Meeting](https://www.federalregister.gov/documents/2026/08/10/2026-16205/national-institute-on-deafness-and-other-communication-disorders-notice-of-meeting) · `2026-16205` - **Notice** [National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting](https://www.federalregister.gov/documents/2026/08/10/2026-16204/national-institute-on-deafness-and-other-communication-disorders-notice-of-closed-meeting) · `2026-16204` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/10/2026-16190/agency-information-collection-activities-proposed-collection-comment-request) · `2026-16190` ## 11 August 2026 — 5 documents - **Notice** [Medicare Program; Regulatory Alignment for Predictable and Immediate Device (RAPID) Coverage Pathway](https://www.federalregister.gov/documents/2026/08/11/2026-16368/medicare-program-regulatory-alignment-for-predictable-and-immediate-device-rapid-coverage-pathway) · `2026-16368` - **Notice** [Reauthorization of the Generic Drug User Fee Amendments; Public Meeting; Request for Comments](https://www.federalregister.gov/documents/2026/08/11/2026-16353/reauthorization-of-the-generic-drug-user-fee-amendments-public-meeting-request-for-comments) · `2026-16353` - **Notice** [Notice of Availability of Final Health Center Program Scope of Project Policy Manual Guidance](https://www.federalregister.gov/documents/2026/08/11/2026-16348/notice-of-availability-of-final-health-center-program-scope-of-project-policy-manual-guidance) · `2026-16348` - **Notice** [Proposed Collection; 60-Day Comment Request Generic Clearance for the Collection of Customer Participation and Performance Management With NIH Programs, Products, and Services (Office of the Director)](https://www.federalregister.gov/documents/2026/08/11/2026-16300/proposed-collection-60-day-comment-request-generic-clearance-for-the-collection-of-customer) · `2026-16300` - **Proposed Rule** [Substances Generally Recognized as Safe](https://www.federalregister.gov/documents/2026/08/11/2026-16296/substances-generally-recognized-as-safe) · `2026-16296` ## 12 August 2026 — 15 documents > The Department of Health and Human Services published fifteen documents on August 12, 2026, comprising thirteen notices, one rule, and one proposed rule. - **Notice** [Government Owned Invention Available for License: MC38 B2m KO Cell Line](https://www.federalregister.gov/documents/2026/08/12/2026-16449/government-owned-invention-available-for-license-mc38-b2m-ko-cell-line) · `2026-16449` - **Notice** [Prospective Grant of an Exclusive Patent License: Development and Commercialization of BL-760 Dye for Intraoperative Fluorescence Imaging](https://www.federalregister.gov/documents/2026/08/12/2026-16444/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-bl-760-dye-for) · `2026-16444` - **Notice** [Government Owned Invention Available for License: Monoclonal Antibody (RO4) That Reacts With the Juxta-Membrane Region of Mesothelin](https://www.federalregister.gov/documents/2026/08/12/2026-16443/government-owned-invention-available-for-license-monoclonal-antibody-ro4-that-reacts-with-the) · `2026-16443` - **Notice** [Government Owned Invention Available for License: Human Antibodies Targeting Beneficial Viral Peptide in Liver Cancer](https://www.federalregister.gov/documents/2026/08/12/2026-16442/government-owned-invention-available-for-license-human-antibodies-targeting-beneficial-viral-peptide) · `2026-16442` - **Notice** [Government Owned Invention Available for License: DNA Methylation-Based Cancer Diagnostics for Accurate Tumor Classification](https://www.federalregister.gov/documents/2026/08/12/2026-16441/government-owned-invention-available-for-license-dna-methylation-based-cancer-diagnostics-for) · `2026-16441` - **Notice** [NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions](https://www.federalregister.gov/documents/2026/08/12/2026-16440/nih-owned-invention-available-for-license-soluble-tissue-factor-a-novel-target-and-antibodies-for) · `2026-16440` - **Notice** [Government Owned Invention Available for License: Quantitative Particle Identification (QPID) Digital Autoradiography System](https://www.federalregister.gov/documents/2026/08/12/2026-16439/government-owned-invention-available-for-license-quantitative-particle-identification-qpid-digital) · `2026-16439` - **Notice** [NIH Owned Invention Available for License: Drug-Regulatable, Inducible Expression of Membrane-Bound Interleukin 12 (DRIM-IL-12) for Use in Adoptive Cell Therapy](https://www.federalregister.gov/documents/2026/08/12/2026-16438/nih-owned-invention-available-for-license-drug-regulatable-inducible-expression-of-membrane-bound) · `2026-16438` - **Rule** [Guide To Minimize Biological Hazards in Ready-to-Eat Fresh-Cut Produce; Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/12/2026-16420/guide-to-minimize-biological-hazards-in-ready-to-eat-fresh-cut-produce-guidance-for-industry) · `2026-16420` - **Proposed Rule** [Adoption and Foster Care Analysis and Reporting System](https://www.federalregister.gov/documents/2026/08/12/2026-16414/adoption-and-foster-care-analysis-and-reporting-system) · `2026-16414` - **Notice** [Solicitation of Nominations for Membership on the National Vaccine Advisory Committee](https://www.federalregister.gov/documents/2026/08/12/2026-16399/solicitation-of-nominations-for-membership-on-the-national-vaccine-advisory-committee) · `2026-16399` - **Notice** [National Newborn Screening Stakeholder Workgroup](https://www.federalregister.gov/documents/2026/08/12/2026-16396/national-newborn-screening-stakeholder-workgroup) · `2026-16396` - **Notice** [Announcement of the Intent To Award Sole-Source Awards to the Federated States of Micronesia and the Republic of the Marshall Islands](https://www.federalregister.gov/documents/2026/08/12/2026-16392/announcement-of-the-intent-to-award-sole-source-awards-to-the-federated-states-of-micronesia-and-the) · `2026-16392` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/12/2026-16386/agency-information-collection-activities-proposed-collection-comment-request) · `2026-16386` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/12/2026-16377/center-for-scientific-review-notice-of-closed-meetings) · `2026-16377` ## 13 August 2026 — 9 documents > The Department of Health and Human Services published eight notices and one rule, including a final rule prohibiting Medicaid and CHIP funding for sex-rejecting procedures in individuals under 18 and 19, respectively. - **Notice** [Government-Owned Inventions; Availability for Licensing](https://www.federalregister.gov/documents/2026/08/13/2026-16544/government-owned-inventions-availability-for-licensing) · `2026-16544` - **Notice** [National Eye Institute; Notice of Meeting](https://www.federalregister.gov/documents/2026/08/13/2026-16538/national-eye-institute-notice-of-meeting) · `2026-16538` - **Notice** [Kremers Urban Pharmaceuticals, Inc.; Grant of Hearing Request Regarding a Proposal To Withdraw Approval of an Abbreviated New Drug Application for Extended-Release Methylphenidate Tablets](https://www.federalregister.gov/documents/2026/08/13/2026-16536/kremers-urban-pharmaceuticals-inc-grant-of-hearing-request-regarding-a-proposal-to-withdraw-approval) · `2026-16536` - **Notice** [Agency Information Collection Activities: Proposed Collection; Public Comment Request: Information Collection Request Title: SAMHSA Data Security Requirements for Accessing Confidential Data (OMB No. 0930-0396)](https://www.federalregister.gov/documents/2026/08/13/2026-16531/agency-information-collection-activities-proposed-collection-public-comment-request-information) · `2026-16531` - **Rule** [Medicaid Program; Prohibition on Federal Medicaid and Children's Health Insurance Program Funding for Sex-Rejecting Procedures Furnished to Children](https://www.federalregister.gov/documents/2026/08/13/2026-16508/medicaid-program-prohibition-on-federal-medicaid-and-childrens-health-insurance-program-funding-for) · `2026-16508` - **Notice** [Medicare Program; Alternative Payment Model (APM) Incentive Payment Advisory for Clinicians-Request for Current Billing Information for Qualifying APM Participants](https://www.federalregister.gov/documents/2026/08/13/2026-16472/medicare-program-alternative-payment-model-apm-incentive-payment-advisory-for-clinicians-request-for) · `2026-16472` - **Notice** [Center For Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/13/2026-16468/center-for-scientific-review-notice-of-closed-meetings) · `2026-16468` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/13/2026-16455/agency-information-collection-activities-proposed-collection-comment-request) · `2026-16455` - **Notice** [Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/13/2026-16452/formal-meetings-between-the-food-and-drug-administration-and-sponsors-or-applicants-of-prescription) · `2026-16452` ## 14 August 2026 — 9 documents > Health and Human Services Department published nine notices, including determinations on drug withdrawals, a cooperative agreement award, guidance on container closure systems, and notices regarding user fees and data collections. - **Notice** [National Institute on Alcohol Abuse and Alcoholism; Notice of Partially Closed Meeting](https://www.federalregister.gov/documents/2026/08/14/2026-16675/national-institute-on-alcohol-abuse-and-alcoholism-notice-of-partially-closed-meeting) · `2026-16675` - **Notice** [Determination That ANSAID (Flurbiprofen) Tablets, 50 Milligrams and 100 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/08/14/2026-16666/determination-that-ansaid-flurbiprofen-tablets-50-milligrams-and-100-milligrams-were-not-withdrawn) · `2026-16666` - **Notice** [Notice of Award of a Single Source Cooperative Agreement To Fund International Rescue Committee](https://www.federalregister.gov/documents/2026/08/14/2026-16658/notice-of-award-of-a-single-source-cooperative-agreement-to-fund-international-rescue-committee) · `2026-16658` - **Notice** [Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments](https://www.federalregister.gov/documents/2026/08/14/2026-16650/reauthorization-of-the-prescription-drug-user-fee-act-public-meeting-request-for-comments) · `2026-16650` - **Notice** [Determination That LASIX (Furosemide) Tablets, 20 Milligrams, 40 Milligrams, and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/08/14/2026-16648/determination-that-lasix-furosemide-tablets-20-milligrams-40-milligrams-and-80-milligrams-were-not) · `2026-16648` - **Notice** [Container Closure Systems for Human Drugs and Biological Products; Draft Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/14/2026-16638/container-closure-systems-for-human-drugs-and-biological-products-draft-guidance-for-industry) · `2026-16638` - **Notice** [Regulatory Agenda](https://www.federalregister.gov/documents/2026/08/14/2026-16597/regulatory-agenda) · `2026-16597` - **Notice** [Proposed Data Collections Submitted for Public Comment and Recommendations](https://www.federalregister.gov/documents/2026/08/14/2026-16594/proposed-data-collections-submitted-for-public-comment-and-recommendations) · `2026-16594` - **Notice** [Submission for Office of Management and Budget Review; Administration for Children and Families Generic for Information Collections Related to Gatherings](https://www.federalregister.gov/documents/2026/08/14/2026-16583/submission-for-office-of-management-and-budget-review-administration-for-children-and-families) · `2026-16583` ## 17 August 2026 — 17 documents > The Department of Health and Human Services published 17 documents on August 17, 2026, comprising 14 notices, two proposed rules, and one final rule. - **Notice** [Agency Information Collection Request; 30-Day Public Comment Request; Submission for Office of Management and Budget Review; Generic Clearance for the Trusted Exchange Framework and Common Agreement (TEFCA) Monitoring Activities](https://www.federalregister.gov/documents/2026/08/17/2026-16766/agency-information-collection-request-30-day-public-comment-request-submission-for-office-of) · `2026-16766` - **Notice** [Proposed Collection: 30-Day Comment Request; Specimen Resource Locator (National Cancer Institute)](https://www.federalregister.gov/documents/2026/08/17/2026-16761/proposed-collection-30-day-comment-request-specimen-resource-locator-national-cancer-institute) · `2026-16761` - **Notice** [Withdrawal of the Announcement of the Intent To Award a Single-Source Cooperative Agreement to Burke Law Group, PLLC in Houston, Texas](https://www.federalregister.gov/documents/2026/08/17/2026-16741/withdrawal-of-the-announcement-of-the-intent-to-award-a-single-source-cooperative-agreement-to-burke) · `2026-16741` - **Notice** [Notice of Award of a Sole Source Cooperative Agreement To Fund Public Health Center of the Ministry of Health of Ukraine](https://www.federalregister.gov/documents/2026/08/17/2026-16733/notice-of-award-of-a-sole-source-cooperative-agreement-to-fund-public-health-center-of-the-ministry) · `2026-16733` - **Notice** [Notice of Award of a Sole Source Cooperative Agreement To Fund University Teaching Hospital in Zambia](https://www.federalregister.gov/documents/2026/08/17/2026-16732/notice-of-award-of-a-sole-source-cooperative-agreement-to-fund-university-teaching-hospital-in) · `2026-16732` - **Notice** [Notice of Award of a Sole Source Cooperative Agreement To Fund the Ministry of Health of Ethiopia](https://www.federalregister.gov/documents/2026/08/17/2026-16731/notice-of-award-of-a-sole-source-cooperative-agreement-to-fund-the-ministry-of-health-of-ethiopia) · `2026-16731` - **Proposed Rule** [Medical Devices; Classification of Accessories Distinct From Other Devices; Proposed List of Accessories Suitable for Class I; Request for Comments](https://www.federalregister.gov/documents/2026/08/17/2026-16729/medical-devices-classification-of-accessories-distinct-from-other-devices-proposed-list-of) · `2026-16729` - **Proposed Rule** [Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer](https://www.federalregister.gov/documents/2026/08/17/2026-16728/gastroenterology-urology-devices-reclassification-of-diagnostic-endoscopic-light-source-systems-to) · `2026-16728` - **Rule** [Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product](https://www.federalregister.gov/documents/2026/08/17/2026-16727/hematology-and-pathology-devices-reclassification-of-in-situ-hybridization-test-systems-for-use-with) · `2026-16727` - **Notice** [Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals](https://www.federalregister.gov/documents/2026/08/17/2026-16716/agency-information-collection-activities-announcement-of-office-of-management-and-budget-approvals) · `2026-16716` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements](https://www.federalregister.gov/documents/2026/08/17/2026-16715/agency-information-collection-activities-proposed-collection-comment-request-investigational-new) · `2026-16715` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food](https://www.federalregister.gov/documents/2026/08/17/2026-16714/agency-information-collection-activities-proposed-collection-comment-request-third-party-disclosure) · `2026-16714` - **Notice** [Determination of Regulatory Review Period for Purposes of Patent Extension; BIZENGRI](https://www.federalregister.gov/documents/2026/08/17/2026-16713/determination-of-regulatory-review-period-for-purposes-of-patent-extension-bizengri) · `2026-16713` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries](https://www.federalregister.gov/documents/2026/08/17/2026-16712/agency-information-collection-activities-proposed-collection-comment-request-imports-and-electronic) · `2026-16712` - **Notice** [Type VII Veterinary Master File for Research and Development and Risk Reviews; Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/17/2026-16711/type-vii-veterinary-master-file-for-research-and-development-and-risk-reviews-guidance-for-industry) · `2026-16711` - **Notice** [Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists](https://www.federalregister.gov/documents/2026/08/17/2026-16706/order-under-sections-362-and-365-of-the-public-health-service-act-continuing-the-suspension-of-the) · `2026-16706` - **Notice** [Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site](https://www.federalregister.gov/documents/2026/08/17/2026-16683/proposed-collection-60-day-comment-request-data-use-certification-for-the-nih-national-institute-on) · `2026-16683` ## 18 August 2026 — 6 documents > The Food and Drug Administration published draft guidance on abbreviated drug application pathways and announced a public workshop on testosterone use in menopausal women. - **Notice** [Determining Whether To Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/18/2026-16837/determining-whether-to-submit-an-anda-or-a-505b2-application-draft-guidance-for-industry) · `2026-16837` - **Notice** [Testosterone Use in Menopausal Women; Public Workshop; Request for Comments](https://www.federalregister.gov/documents/2026/08/18/2026-16829/testosterone-use-in-menopausal-women-public-workshop-request-for-comments) · `2026-16829` - **Notice** [Tribal Consultation Meeting](https://www.federalregister.gov/documents/2026/08/18/2026-16826/tribal-consultation-meeting) · `2026-16826` - **Notice** [Submission for Office of Management and Budget Review; ACF-700 Tribal Annual Report](https://www.federalregister.gov/documents/2026/08/18/2026-16793/submission-for-office-of-management-and-budget-review-acf-700-tribal-annual-report) · `2026-16793` - **Notice** [National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting](https://www.federalregister.gov/documents/2026/08/18/2026-16779/national-institute-of-allergy-and-infectious-diseases-amended-notice-of-meeting) · `2026-16779` - **Notice** [National Institute of Neurological Disorders and Stroke; Notice of Partially Closed Meeting](https://www.federalregister.gov/documents/2026/08/18/2026-16778/national-institute-of-neurological-disorders-and-stroke-notice-of-partially-closed-meeting) · `2026-16778` ## 19 August 2026 — 10 documents > The Food and Drug Administration published three proposed rules on color additive petitions and one final rule permitting chromium DL-methionine chelate in animal feed. - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/19/C1-2026-15326/agency-information-collection-activities-proposed-collection-comment-request) · `C1-2026-15326` - **Proposed Rule** [Gardenia Blue Interest Group; Filing of Color Additive Petition](https://www.federalregister.gov/documents/2026/08/19/2026-16944/gardenia-blue-interest-group-filing-of-color-additive-petition) · `2026-16944` - **Proposed Rule** [International Association of Color Manufacturers; Filing of Color Additive Petition](https://www.federalregister.gov/documents/2026/08/19/2026-16943/international-association-of-color-manufacturers-filing-of-color-additive-petition) · `2026-16943` - **Rule** [Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate](https://www.federalregister.gov/documents/2026/08/19/2026-16942/food-additives-permitted-in-feed-and-drinking-water-of-animals-chromium-dl-methionine-chelate) · `2026-16942` - **Proposed Rule** [GNT USA, LLC.; Filing of Color Additive Petition](https://www.federalregister.gov/documents/2026/08/19/2026-16939/gnt-usa-llc-filing-of-color-additive-petition) · `2026-16939` - **Notice** [Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Voluntary Partner Survey on HRSA Customer Service, OMB No. 0906-0084-Revision](https://www.federalregister.gov/documents/2026/08/19/2026-16912/agency-information-collection-activities-proposed-collection-public-comment-request-information) · `2026-16912` - **Notice** [Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Health Professions Student Loan Program, Loans for Disadvantaged Students Program, Primary Care Loan Program, and Nursing Student Loan Program Administrative Requirements, OMB No. 0906-0088-Extension](https://www.federalregister.gov/documents/2026/08/19/2026-16878/agency-information-collection-activities-submission-to-omb-for-review-and-approval-public-comment) · `2026-16878` - **Notice** [Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Rural Maternity and Obstetrics Management Strategies Program Data Collection, OMB No. 0915-0394-Revision](https://www.federalregister.gov/documents/2026/08/19/2026-16871/agency-information-collection-activities-proposed-collection-public-comment-request-information) · `2026-16871` - **Notice** [Notice of Award of a Sole Source Cooperative Agreement To Fund Ministry of Health Zambia](https://www.federalregister.gov/documents/2026/08/19/2026-16865/notice-of-award-of-a-sole-source-cooperative-agreement-to-fund-ministry-of-health-zambia) · `2026-16865` - **Notice** [Solicitation of Nominations for Appointment to the World Trade Center Health Program Scientific/Technical Advisory Committee](https://www.federalregister.gov/documents/2026/08/19/2026-16852/solicitation-of-nominations-for-appointment-to-the-world-trade-center-health-program) · `2026-16852` ## 20 August 2026 — 13 documents > The Health and Human Services Department published thirteen notices on August 20, 2026, including paperwork reduction act reviews, advisory committee renewals, and guidance documents. - **Notice** [Agency Forms Undergoing Paperwork Reduction Act Review](https://www.federalregister.gov/documents/2026/08/20/2026-17043/agency-forms-undergoing-paperwork-reduction-act-review) · `2026-17043` - **Notice** [Proposed Data Collection Submitted for Public Comment and Recommendations](https://www.federalregister.gov/documents/2026/08/20/2026-17040/proposed-data-collection-submitted-for-public-comment-and-recommendations) · `2026-17040` - **Notice** [Proposed Data Collection Submitted for Public Comment and Recommendations](https://www.federalregister.gov/documents/2026/08/20/2026-17037/proposed-data-collection-submitted-for-public-comment-and-recommendations) · `2026-17037` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/20/2026-17017/center-for-scientific-review-notice-of-closed-meetings) · `2026-17017` - **Notice** [Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Black Lung Clinics Program Performance Measures](https://www.federalregister.gov/documents/2026/08/20/2026-17009/agency-information-collection-activities-submission-to-omb-for-review-and-approval-public-comment) · `2026-17009` - **Notice** [Privacy Act of 1974; System of Records](https://www.federalregister.gov/documents/2026/08/20/2026-17005/privacy-act-of-1974-system-of-records) · `2026-17005` - **Notice** [Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal](https://www.federalregister.gov/documents/2026/08/20/2026-16999/advisory-committee-cardiovascular-and-renal-drugs-advisory-committee-renewal) · `2026-16999` - **Notice** [Advisory Committee; Endocrinologic and Metabolic Drugs Advisory Committee; Renewal](https://www.federalregister.gov/documents/2026/08/20/2026-16998/advisory-committee-endocrinologic-and-metabolic-drugs-advisory-committee-renewal) · `2026-16998` - **Notice** [Potency Assessment of Active Immunotherapy Products; Draft Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/20/2026-16960/potency-assessment-of-active-immunotherapy-products-draft-guidance-for-industry-availability) · `2026-16960` - **Notice** [Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/20/2026-16959/frequently-asked-questions-developing-potential-cellular-and-gene-therapy-products-final-guidance) · `2026-16959` - **Notice** [Center or Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/20/2026-16958/center-or-scientific-review-notice-of-closed-meetings) · `2026-16958` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/20/2026-16957/center-for-scientific-review-notice-of-closed-meetings) · `2026-16957` - **Notice** [Privacy Act of 1974; System of Records](https://www.federalregister.gov/documents/2026/08/20/2026-16933/privacy-act-of-1974-system-of-records) · `2026-16933` ## 21 August 2026 — 7 documents > The Health and Human Services Department published seven notices on August 21, 2026, including information collection requests and a government-owned invention available for license. - **Notice** [Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: Faculty Loan Repayment Program, OMB No. 0906-0082-Revision](https://www.federalregister.gov/documents/2026/08/21/2026-17190/agency-information-collection-activities-proposed-collection-public-comment-request-information) · `2026-17190` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/21/2026-17164/agency-information-collection-activities-proposed-collection-comment-request) · `2026-17164` - **Notice** [Government Owned Invention Available for License: Matched Patient-Derived 3D Isocitrate Dehydrogenase (IDH)-Mutant Glioma Cell Lines for Modeling Malignant Transformation](https://www.federalregister.gov/documents/2026/08/21/2026-17157/government-owned-invention-available-for-license-matched-patient-derived-3d-isocitrate-dehydrogenase) · `2026-17157` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/21/2026-17156/center-for-scientific-review-notice-of-closed-meetings) · `2026-17156` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/21/2026-17128/agency-information-collection-activities-proposed-collection-comment-request) · `2026-17128` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/21/2026-17112/agency-information-collection-activities-proposed-collection-comment-request) · `2026-17112` - **Notice** [Advisory Committee; Oncologic Drugs Advisory Committee; Renewal](https://www.federalregister.gov/documents/2026/08/21/2026-17084/advisory-committee-oncologic-drugs-advisory-committee-renewal) · `2026-17084` ## 24 August 2026 — 5 documents - **Notice** [Request for Information: Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision-Making](https://www.federalregister.gov/documents/2026/08/24/2026-17250/request-for-information-categories-used-in-federal-vaccine-recommendations-and-the-role-of-shared) · `2026-17250` - **Notice** [Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 066](https://www.federalregister.gov/documents/2026/08/24/2026-17229/food-and-drug-administration-modernization-act-of-1997-modifications-to-the-list-of-recognized) · `2026-17229` - **Notice** [Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability](https://www.federalregister.gov/documents/2026/08/24/2026-17222/product-specific-guidances-draft-and-revised-draft-guidances-for-industry-availability) · `2026-17222` - **Notice** [Evaluation of Therapeutic Equivalence; Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/08/24/2026-17215/evaluation-of-therapeutic-equivalence-guidance-for-industry-availability) · `2026-17215` - **Notice** [Government Owned Invention Available for License: T Cell Receptors Targeting HPV 6 or HPV 11](https://www.federalregister.gov/documents/2026/08/24/2026-17188/government-owned-invention-available-for-license-t-cell-receptors-targeting-hpv-6-or-hpv-11) · `2026-17188` ## 25 August 2026 — 5 documents > The Department of Health and Human Services published five notices on August 25, 2026, including a request for information on emerging science relevant to the National Institute on Deafness and Other Communication Disorders' strategic plan. - **Notice** [Request for Information (RFI): Request for Information on New and Emerging Areas of Science Relevant to the NIDCD Mission, To Inform an Update of the NIDCD Strategic Plan for 2028-2032](https://www.federalregister.gov/documents/2026/08/25/2026-17311/request-for-information-rfi-request-for-information-on-new-and-emerging-areas-of-science-relevant-to) · `2026-17311` - **Notice** [National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting](https://www.federalregister.gov/documents/2026/08/25/2026-17270/national-institute-of-diabetes-and-digestive-and-kidney-diseases-amended-notice-of-meeting) · `2026-17270` - **Notice** [Office of the Director, National Institutes of Health; Notice of Meeting](https://www.federalregister.gov/documents/2026/08/25/2026-17269/office-of-the-director-national-institutes-of-health-notice-of-meeting) · `2026-17269` - **Notice** [National Heart, Lung, and Blood Institute; Notice of Closed Meeting](https://www.federalregister.gov/documents/2026/08/25/2026-17267/national-heart-lung-and-blood-institute-notice-of-closed-meeting) · `2026-17267` - **Notice** [National Heart, Lung, and Blood Institute; Notice of Meeting](https://www.federalregister.gov/documents/2026/08/25/2026-17266/national-heart-lung-and-blood-institute-notice-of-meeting) · `2026-17266` ## 26 August 2026 — 5 documents - **Notice** [Hydroxymitragynine Above a Specified Threshold in Schedule I; Extension of Comment Period](https://www.federalregister.gov/documents/2026/08/26/2026-17409/hydroxymitragynine-above-a-specified-threshold-in-schedule-i-extension-of-comment-period) · `2026-17409` - **Notice** [Meeting of the Microbiome Subcommittee of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria](https://www.federalregister.gov/documents/2026/08/26/2026-17404/meeting-of-the-microbiome-subcommittee-of-the-presidential-advisory-council-on-combating) · `2026-17404` - **Notice** [Determination That CABAZITAXEL (Cabazitaxel) Solution (Injection), 60 Milligrams/6 Milliliters (10 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/08/26/2026-17401/determination-that-cabazitaxel-cabazitaxel-solution-injection-60-milligrams6-milliliters-10) · `2026-17401` - **Notice** [International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments](https://www.federalregister.gov/documents/2026/08/26/2026-17380/international-drug-scheduling-single-convention-on-narcotic-drugs-convention-on-psychotropic) · `2026-17380` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Allegations of Regulatory Misconduct Voluntarily Submitted to the Center for Devices and Radiological Health](https://www.federalregister.gov/documents/2026/08/26/2026-17377/agency-information-collection-activities-proposed-collection-comment-request-allegations-of) · `2026-17377` ## 27 August 2026 — 8 documents > The Health and Human Services Department published eight notices on August 27, 2026, including closed meeting notices, a drug efficacy study implementation extension, and cooperative agreement awards. - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/27/2026-17535/center-for-scientific-review-notice-of-closed-meetings) · `2026-17535` - **Notice** [Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Second Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661](https://www.federalregister.gov/documents/2026/08/27/2026-17498/drugs-for-human-use-drug-efficacy-study-implementation-estrogen-androgen-fixed-combination-drug) · `2026-17498` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/27/2026-17484/agency-information-collection-activities-proposed-collection-comment-request) · `2026-17484` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/27/2026-17452/center-for-scientific-review-notice-of-closed-meetings) · `2026-17452` - **Notice** [Center for Scientific Review; Amended Notice of Meeting](https://www.federalregister.gov/documents/2026/08/27/2026-17451/center-for-scientific-review-amended-notice-of-meeting) · `2026-17451` - **Notice** [Notice of Award of a Sole Source Cooperative Agreement To Fund Vietnam Administration of Medical Services, National Institute of Medical Research, and ASEAN-Plus Field Epidemiology Training Network Foundation](https://www.federalregister.gov/documents/2026/08/27/2026-17450/notice-of-award-of-a-sole-source-cooperative-agreement-to-fund-vietnam-administration-of-medical) · `2026-17450` - **Notice** [Notice of Award of a Single Source Cooperative Agreement To Fund Elizabeth Glaser Pediatric AIDS Foundation](https://www.federalregister.gov/documents/2026/08/27/2026-17449/notice-of-award-of-a-single-source-cooperative-agreement-to-fund-elizabeth-glaser-pediatric-aids) · `2026-17449` - **Notice** [Center For Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/27/2026-17438/center-for-scientific-review-notice-of-closed-meetings) · `2026-17438` ## 28 August 2026 — 11 documents > The Department of Health and Human Services published ten notices and one rule on August 28, 2026, including corrections to federal independent dispute resolution operations and multiple information collection requests. - **Notice** [Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: The National Health Service Corps Loan Repayment Programs OMB No. 0915-0127-Revision](https://www.federalregister.gov/documents/2026/08/28/2026-17625/agency-information-collection-activities-proposed-collection-public-comment-request-information) · `2026-17625` - **Notice** [Proposed Data Collection Submitted for Public Comment and Recommendations](https://www.federalregister.gov/documents/2026/08/28/2026-17624/proposed-data-collection-submitted-for-public-comment-and-recommendations) · `2026-17624` - **Notice** [Agency Forms Undergoing Paperwork Reduction Act Review](https://www.federalregister.gov/documents/2026/08/28/2026-17623/agency-forms-undergoing-paperwork-reduction-act-review) · `2026-17623` - **Rule** [Federal Independent Dispute Resolution Operations; Correction](https://www.federalregister.gov/documents/2026/08/28/2026-17622/federal-independent-dispute-resolution-operations-correction) · `2026-17622` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Qualitative Feedback on Agency Service Delivery](https://www.federalregister.gov/documents/2026/08/28/2026-17605/agency-information-collection-activities-proposed-collection-comment-request-qualitative-feedback-on) · `2026-17605` - **Notice** [Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Importation of Prescription Drugs](https://www.federalregister.gov/documents/2026/08/28/2026-17603/agency-information-collection-activities-submission-for-office-of-management-and-budget-review) · `2026-17603` - **Notice** [Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees](https://www.federalregister.gov/documents/2026/08/28/2026-17601/agency-information-collection-activities-submission-for-office-of-management-and-budget-review) · `2026-17601` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Food Canning Establishment Registration, Process Filing, and Recordkeeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically Sealed Containers](https://www.federalregister.gov/documents/2026/08/28/2026-17599/agency-information-collection-activities-proposed-collection-comment-request-food-canning) · `2026-17599` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Focus Groups and Interviews as Used by the Food and Drug Administration](https://www.federalregister.gov/documents/2026/08/28/2026-17598/agency-information-collection-activities-proposed-collection-comment-request-focus-groups-and) · `2026-17598` - **Notice** [Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/08/28/2026-17580/compounding-animal-drugs-from-bulk-drug-substances-compounding-under-cgmp-in-federally-registered) · `2026-17580` - **Notice** [Submission for Office of Management and Budget Review; National and State Survey of Child and Adolescent Well-Being (NSSCAW): Site Recruitment and Baseline Data Collection](https://www.federalregister.gov/documents/2026/08/28/2026-17545/submission-for-office-of-management-and-budget-review-national-and-state-survey-of-child-and) · `2026-17545` ## 31 August 2026 — 10 documents > The Health and Human Services Department published ten notices on August 31, 2026, including authorizations for emergency use of animal drugs for New World screwworm treatment. - **Notice** [Notice of Interest Rate on Overdue Debts](https://www.federalregister.gov/documents/2026/08/31/2026-17759/notice-of-interest-rate-on-overdue-debts) · `2026-17759` - **Notice** [Submission for Office of Management and Budget Review; Head Start State Collaboration Office Grant Application](https://www.federalregister.gov/documents/2026/08/31/2026-17745/submission-for-office-of-management-and-budget-review-head-start-state-collaboration-office-grant) · `2026-17745` - **Notice** [Authorization of Emergency Use for Three Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability](https://www.federalregister.gov/documents/2026/08/31/2026-17719/authorization-of-emergency-use-for-three-animal-drugs-for-the-prevention-and-treatment-of-new-world) · `2026-17719` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/08/31/2026-17687/center-for-scientific-review-notice-of-closed-meetings) · `2026-17687` - **Notice** [National Center for Advancing Translational Sciences; Amended Notice of Meeting](https://www.federalregister.gov/documents/2026/08/31/2026-17686/national-center-for-advancing-translational-sciences-amended-notice-of-meeting) · `2026-17686` - **Notice** [Notice of Public Hearing: NIAID Proposed Reorganization](https://www.federalregister.gov/documents/2026/08/31/2026-17685/notice-of-public-hearing-niaid-proposed-reorganization) · `2026-17685` - **Notice** [Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Potential Tobacco Product Violations Reporting Form](https://www.federalregister.gov/documents/2026/08/31/2026-17677/agency-information-collection-activities-submission-for-office-of-management-and-budget-review) · `2026-17677` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Human Drug Compounding Outsourcing Facilities Under the Federal Food, Drug, and Cosmetic Act and Associated Fees](https://www.federalregister.gov/documents/2026/08/31/2026-17676/agency-information-collection-activities-proposed-collection-comment-request-registration-of-human) · `2026-17676` - **Notice** [Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Reports of Removals and Corrections](https://www.federalregister.gov/documents/2026/08/31/2026-17675/agency-information-collection-activities-proposed-collection-comment-request-medical-devices-reports) · `2026-17675` - **Notice** [Rahim Shafa; Denial of Hearing; Final Debarment Order](https://www.federalregister.gov/documents/2026/08/31/2026-17659/rahim-shafa-denial-of-hearing-final-debarment-order) · `2026-17659` ## 1 September 2026 — 10 documents > The Department of Health and Human Services published ten notices, including meeting notices for multiple institutes, an information collection request comment period closing November 2, and a list of certified drug testing laboratories. - **Notice** [National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting](https://www.federalregister.gov/documents/2026/09/01/2026-17897/national-institute-on-alcohol-abuse-and-alcoholism-notice-of-closed-meeting) · `2026-17897` - **Notice** [Center for Scientific Review; Notice of Closed Meetings](https://www.federalregister.gov/documents/2026/09/01/2026-17896/center-for-scientific-review-notice-of-closed-meetings) · `2026-17896` - **Notice** [National Institute on Drug Abuse; Notice of Meeting](https://www.federalregister.gov/documents/2026/09/01/2026-17879/national-institute-on-drug-abuse-notice-of-meeting) · `2026-17879` - **Notice** [Agency Information Collection Activities: Proposed Collection; Comment Request](https://www.federalregister.gov/documents/2026/09/01/2026-17875/agency-information-collection-activities-proposed-collection-comment-request) · `2026-17875` - **Notice** [Emergency Office of Management and Budget Review and Public Comment: Questionnaire for the Refugee Outreach and Well-Being Initiative](https://www.federalregister.gov/documents/2026/09/01/2026-17856/emergency-office-of-management-and-budget-review-and-public-comment-questionnaire-for-the-refugee) · `2026-17856` - **Notice** [Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies](https://www.federalregister.gov/documents/2026/09/01/2026-17852/current-list-of-hhs-certified-laboratories-and-instrumented-initial-testing-facilities-which-meet) · `2026-17852` - **Notice** [Center for Scientific Review; Amended Notice of Meeting](https://www.federalregister.gov/documents/2026/09/01/2026-17850/center-for-scientific-review-amended-notice-of-meeting) · `2026-17850` - **Notice** [National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting](https://www.federalregister.gov/documents/2026/09/01/2026-17849/national-institute-of-allergy-and-infectious-diseases-amended-notice-of-meeting) · `2026-17849` - **Notice** [Determination That NAMENDA (Memantine Hydrochloride) Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/09/01/2026-17812/determination-that-namenda-memantine-hydrochloride-tablets-5-milligrams-and-10-milligrams-were-not) · `2026-17812` - **Notice** [Meeting of the Microbiome Subcommittee of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria; Correction](https://www.federalregister.gov/documents/2026/09/01/2026-17793/meeting-of-the-microbiome-subcommittee-of-the-presidential-advisory-council-on-combating) · `2026-17793` ## 2 September 2026 — 12 documents > The Department of Health and Human Services published twelve notices in the Federal Register on September 2, 2026. - **Notice** [Prospective Grant of an Exclusive Patent License: Development and Commercialization of Mifepristone and Analogues To Treat Hypercortisolism-Related Insulin Resistance Disorders](https://www.federalregister.gov/documents/2026/09/02/2026-17991/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-mifepristone) · `2026-17991` - **Notice** [Submission for Office of Management and Budget Review; TANF Contingency Fund Application](https://www.federalregister.gov/documents/2026/09/02/2026-17982/submission-for-office-of-management-and-budget-review-tanf-contingency-fund-application) · `2026-17982` - **Notice** [Agency Information Collection Activities: Submission for OMB Review; Comment Request](https://www.federalregister.gov/documents/2026/09/02/2026-17970/agency-information-collection-activities-submission-for-omb-review-comment-request) · `2026-17970` - **Notice** [Determination That CARAFATE (Sucralfate) Oral Suspension, 1 Gram/10 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/09/02/2026-17968/determination-that-carafate-sucralfate-oral-suspension-1-gram10-milliliters-was-not-withdrawn-from) · `2026-17968` - **Notice** [Pharmacokinetics in Patients With Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosage; Draft Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/09/02/2026-17961/pharmacokinetics-in-patients-with-impaired-hepatic-function-study-design-data-analysis-and-impact-on) · `2026-17961` - **Notice** [Announcement of the Intent To Award a Single-Source Cooperative Agreement to Spaulding for Children for the National Training and Development Curriculum for Foster/Adoptive Parents (NTDC) in Southfield, Michigan](https://www.federalregister.gov/documents/2026/09/02/2026-17959/announcement-of-the-intent-to-award-a-single-source-cooperative-agreement-to-spaulding-for-children) · `2026-17959` - **Notice** [Dental Composite Resin Devices and Dental Curing Lights-Premarket Notification (510(k)) Submissions Guidances; Guidances for Industry and Food and Drug Administration Staff; Availability](https://www.federalregister.gov/documents/2026/09/02/2026-17933/dental-composite-resin-devices-and-dental-curing-lights-premarket-notification-510k-submissions) · `2026-17933` - **Notice** [Issuance of Priority Review Voucher; Rare Pediatric Disease Product; GENGLYCOS (parisglasgene brecaparvovec-opnr)](https://www.federalregister.gov/documents/2026/09/02/2026-17932/issuance-of-priority-review-voucher-rare-pediatric-disease-product-genglycos-parisglasgene) · `2026-17932` - **Notice** [International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Studies To Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Genotoxicity Testing (Revision 2); Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/09/02/2026-17928/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary) · `2026-17928` - **Notice** [International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Studies To Evaluate the Safety of Residues of Veterinary Drugs in Human Food: Reproduction Testing (Revision 1); Guidance for Industry; Availability](https://www.federalregister.gov/documents/2026/09/02/2026-17927/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary) · `2026-17927` - **Notice** [Privacy Act of 1974; Matching Program](https://www.federalregister.gov/documents/2026/09/02/2026-17907/privacy-act-of-1974-matching-program) · `2026-17907` - **Notice** [Proposed Collection; 60-Day Comment Request; Assurance (Interinstitutional, Foreign, and Domestic) and Annual Report (Office of the Director)](https://www.federalregister.gov/documents/2026/09/02/2026-17899/proposed-collection-60-day-comment-request-assurance-interinstitutional-foreign-and-domestic-and) · `2026-17899` ## 3 September 2026 — 4 documents > The Department of Health and Human Services published four notices including an information collection request, a drug withdrawal determination, an emergency use authorization declaration, and a meeting notice. - **Notice** [Agency Information Collection Request. 30-Day Public Comment Request](https://www.federalregister.gov/documents/2026/09/03/2026-18060/agency-information-collection-request-30-day-public-comment-request) · `2026-18060` - **Notice** [Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness](https://www.federalregister.gov/documents/2026/09/03/2026-18023/determination-that-phenaphen-with-codeine-no-3-acetaminophen-codeine-phosphate-oral-capsules-325) · `2026-18023` - **Notice** [Emergency Use Authorization Declaration](https://www.federalregister.gov/documents/2026/09/03/2026-18008/emergency-use-authorization-declaration) · `2026-18008` - **Notice** [National Institute of Mental Health; Notice of Meeting](https://www.federalregister.gov/documents/2026/09/03/2026-17989/national-institute-of-mental-health-notice-of-meeting) · `2026-17989` ## 4 September 2026 — 4 documents - **Proposed Rule** [Reducing Bureaucracy and Burden for the Repatriation of Mentally Ill Nationals](https://www.federalregister.gov/documents/2026/09/04/2026-18167/reducing-bureaucracy-and-burden-for-the-repatriation-of-mentally-ill-nationals) · `2026-18167` - **Notice** [Advancing Development of Botanical Drug Products; Request for Information](https://www.federalregister.gov/documents/2026/09/04/2026-18133/advancing-development-of-botanical-drug-products-request-for-information) · `2026-18133` - **Notice** [Performance Review Board Members](https://www.federalregister.gov/documents/2026/09/04/2026-18120/performance-review-board-members) · `2026-18120` - **Notice** [Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Information Collection Request Title: Rural Communities Opioid Response Program Performance Measures, OMB No. 0906-XXXX-New](https://www.federalregister.gov/documents/2026/09/04/2026-18115/agency-information-collection-activities-submission-to-omb-for-review-and-approval-public-comment) · `2026-18115` ## Ask an assistant instead Everything on this page is also a tool call. Add `mcp.downstream.sh` as an MCP server — no key, no account — then paste this: ``` Using the Downstream MCP server at mcp.downstream.sh, call whats_new_since with agency "Health and Human Services Department" since 2026-08-10, then tell me what this agency has been working on and which of its deadlines are still open. ``` Reaches `whats_new_since`. The response carries its own citations and states what it is missing, including which dates it has no record for. --- Every document linked here is a work of the United States government and in the public domain. The Federal Register's HTML and XML renderings are unofficial; the PDF on each item is the official text, and that is the one to cite. Counts are arithmetic over published fields, dates are printed as filed, and titles are verbatim. Where we have nothing, this says nothing rather than estimating. The one-sentence agency summaries are machine-written from those same fields and are labelled where they appear. [Downstream](https://downstream.sh/) · [the essay](https://downstream.sh/essays/a-country-that-can-see.html) · [the daily issue](https://downstream.sh/daily/) · [MCP endpoint](https://mcp.downstream.sh)